Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Glycyrrhetinic acid-hydrogen sulfide donor reagent derivative, and synthetic method and application thereof

A hydrogen sulfide donor, glycyrrhetic acid technology, applied in the field of medicine, can solve problems such as no synthesis method and application.

Inactive Publication Date: 2016-12-21
GUANGXI NORMAL UNIV
View PDF10 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, there are no relevant reports on the derivatives of glycyrrhetinic acid and hydrogen sulfide donor reagents connected through alkane chains and their synthesis methods and applications.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Glycyrrhetinic acid-hydrogen sulfide donor reagent derivative, and synthetic method and application thereof
  • Glycyrrhetinic acid-hydrogen sulfide donor reagent derivative, and synthetic method and application thereof
  • Glycyrrhetinic acid-hydrogen sulfide donor reagent derivative, and synthetic method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Embodiment 1: the synthesis of compound 1a

[0042] Dissolve glycyrrhetinic acid (500mg, 1.06mmol) in anhydrous DMF (5mL), add 1,6-dibromoethane (2.43mL, 5.3mmol), K 2 CO 3 (146.28mg, 1.06mmol), reacted at 30°C for 24h. The solvent was evaporated under reduced pressure, and the residue was dispersed in ethyl acetate (50 mL), washed successively with HCl (1N), water, and saturated brine, dried over anhydrous sodium sulfate, filtered, the filtrate was concentrated under reduced pressure, and separated by column chromatography (V PE :V EA =2:1), to obtain compound 1a (457mg, 75%, white solid).

[0043] Yield: 457mg, 75%, white solid; R f =0.461 (Petroluem ether:EtOAc=2:1).M.p 190-192°C. 1 H NMR (500MHz, CDCl 3)δ (ppm): 5.69 (s, 1H, 12-H), 4.41 (dd, J = 28.0, 5.9Hz, 2H, OCH 2 ), 3.53(t, J=5.7Hz, 2H, OCH 2 ),3.21(dd,J=11.0,5.2Hz,1H,3-H),2.83-2.71(m,1H,18-H),2.32(s,1H),2.21-0.63(m,20H),1.35 , 1.17, 1.12, 1.11, 0.99, 0.80 and 0.79 (7s, each 3H, 7×CH 3 ). 13 C NMR (1...

Embodiment 2

[0045] Embodiment 2: the synthesis of compound 1b

[0046] Dissolve glycyrrhetinic acid (500mg, 1.06mmol) in anhydrous DMF (5mL), add 1,8-dibromobutane (2.94mL, 5.3mmol), K 2 CO 3 (146.28mg, 1.06mmol), reacted at 30°C for 24h. The solvent was evaporated under reduced pressure, and the residue was dispersed in ethyl acetate (50 mL), washed successively with HCl (1N), water, and saturated brine, dried over anhydrous sodium sulfate, filtered, the filtrate was concentrated under reduced pressure, and separated by column chromatography (V PE :V EA =2:1), to obtain compound 1b (532mg, 83%, white solid).

[0047] Yield: 532mg, 83%, white solid; R f =0.515 (Petroluem ether:EtOAc=2:1).M.p 82-84°C. 1 H NMR (500MHz, CDCl 3 )δ (ppm): 5.61 (s, 1H, 12-H), 4.12 (t, J = 6.3Hz, 2H, OCH 2 ), 3.43(t, J=6.5Hz, 2H, OCH 2 ), 3.21(dd, J=11.1, 5.1Hz, 1H, 3-H), 2.77(d, J=13.5Hz, 1H, 18-H), 2.32(s, 1H), 2.13-0.61(m, 24H ), 1.35, 1.14, 1.11, 1.10 and 0.98 (5s, each 3H, 5×CH 3 ),0.79(s,6H,2×CH ...

Embodiment 3

[0049] Embodiment 3: the synthesis of compound 1c

[0050] Dissolve glycyrrhetinic acid (1.0g, 2.12mmol) in anhydrous DMF (5mL), add 1,6-dibromohexane (1.62mL, 10.62mmol), K 2 CO 3 (293.0mg, 2.12mmol), reacted at 30°C for 24h. The solvent was evaporated under reduced pressure, the residue was dispersed in ethyl acetate (50ml), washed successively with HCl (1N), water, and saturated brine, dried over anhydrous sodium sulfate, filtered, the filtrate was concentrated under reduced pressure, and separated by column chromatography (V PE :V EA =5:2), to obtain compound 1c (929mg, 69%, white solid).

[0051] Yield: 929mg, 69%, white solid; R f =0.452 (Petroluem ether:EtOAc=5:2).M.p 102-104°C. 1 H NMR (500MHz, CDCl 3 )δ (ppm): 5.61 (s, 1H, 12-H), 4.08 (m, 2H, OCH 2 ),3.39(m,2H,CH 2 -Br), 3.20(dd, J=11.1, 5.2Hz, 1H, 3-H), 2.76(d, J=13.5Hz, 1H, 18-H), 2.32(s, 1H, 10-H), 2.09 -0.69(m,35H),1.35,1.13,1.11,1.10and 0.98(5s,each 3H,5×CH 3 ),0.79(s,6H,2×CH 3 ). 13 C NMR (125MHz, CD...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a glycyrrhetinic acid-hydrogen sulfide donor reagent derivative, and a synthetic method and an application thereof. The synthetic method of the derivative comprises the following steps: carrying out a reaction on glycyrrhetinic acid, alpha,omega-dibromoalkane and an alkali in an aprotic polar solvent to obtain a compound 1; and carrying out a reaction on the compound 1, a hydrogen sulfide donor and the alkali in the aprotic polar solvent to obtain a crude target product, wherein the reactions are carried out under heating or non-heating conditions. Most compounds in the synthesized derivative have certain inhibition activity to a chronic marrow leukemia cell K562, and are hopeful to be used in the preparation of corresponding antitumor medicines and chronic marrow leukemia cell treatment medicines. The synthesized derivative has a structure represented by general formula (I) shown in the description; and in the general formula (I), n is 2-8, and R is one of three formulas shown in the description.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a glycyrrhetinic acid-hydrogen sulfide donor reagent derivative and its synthesis method and application. Background technique [0002] Hydrogen sulfide is a new biologically active gas molecule following CO and NO. It is an important role in supporting life. It has an irreplaceable physiological regulatory role in life activities, controls a variety of intracellular signal transduction processes and exerts positive regulation effect. At present, the potential therapeutic application of hydrogen sulfide mainly focuses on the nervous and cardiovascular systems, such as the treatment of hypertension, the treatment of cardiac ischemic diseases, the treatment of atherosclerosis, and the combination with non-steroidal anti-inflammatory drugs to reduce the Metabolism, prevention of hypoxic damage, etc. [0003] Hydrogen sulfide donors can be hydrolyzed and spontaneously emit H under...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07J63/00A61K31/56A61K31/58A61P35/02
CPCC07J63/008
Inventor 程克光黄家艳张琚政莫伟彬邓胜平
Owner GUANGXI NORMAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com